Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$134K Buy
+92,960
New +$168K ﹤0.01% 5428
2026
Q1
Sell
-34,775
Closed -$64K 6071
2025
Q4
$64K Buy
+34,775
New +$87.9K ﹤0.01% 5703
2025
Q1
Sell
-25,380
Closed -$32.2K 6165
2024
Q4
$32.2K Buy
+25,380
New +$29.3K ﹤0.01% 5656
2023
Q4
Sell
-22,465
Closed -$142K 6332
2023
Q3
$142K Sell
22,465
-5,951
-21% -$47.8K ﹤0.01% 5235
2023
Q2
$154K Buy
+28,416
New +$176K ﹤0.01% 5217
2023
Q1
Sell
-11,210
Closed -$162K 6632
2022
Q4
$162K Sell
11,210
-3,328
-23% -$86.3K ﹤0.01% 5407
2022
Q3
$484K Buy
14,538
+10,612
+270% +$592K ﹤0.01% 5005
2022
Q2
$225K Sell
3,926
-9,969
-72% -$1.35M ﹤0.01% 5575
2022
Q1
$2.28M Buy
13,895
+13,352
+2,459% +$1.53M ﹤0.01% 3754
2021
Q4
$79K Sell
543
-6,458
-92% -$995K ﹤0.01% 6343
2021
Q3
$1.15M Buy
7,001
+5,080
+264% +$1.41M ﹤0.01% 4524
2021
Q2
$578K Sell
1,921
-1,180
-38% -$354K ﹤0.01% 5165
2021
Q1
$930K Buy
+3,101
New +$1.05M ﹤0.01% 4285

Other funds holding LIDR

Israel Englander's LIDR Position: Q2 2026 in Review

Israel Englander opened a new position in AEye (LIDR) in Q2 2026: 92,960 shares worth $134K. The stake represents ﹤0.01% of the portfolio and ranks #5428 among its holdings. This is a return to the name: Israel Englander previously reported a position in LIDR as recently as Q4 2025.

Israel Englander first reported a position in LIDR in Q1 2021 and has held it in 13 quarters since. The position peaked at $2.28M in Q1 2022. 51 funds tracked by Wall St. Rank hold LIDR as of Q2 2026.

  • Israel Englander held 92,960 shares of AEye worth $134K as of Q2 2026.
  • AEye was a new Israel Englander position in Q2 2026.
  • AEye made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5428 holding.
  • Israel Englander first reported a position in AEye in Q1 2021 and has held it in 13 quarters since.
  • Israel Englander's AEye position peaked at $2.28M in Q1 2022.
  • 51 funds tracked by Wall St. Rank held AEye as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.